Shares of DocGo Inc. (NASDAQ:DCGO – Get Free Report) have been assigned an average rating of “Hold” from the six research firms that are currently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and three have given a buy recommendation to the company. The average 1 year price objective among brokerages that have issued ratings on the stock in the last year is $2.3750.
DCGO has been the subject of a number of recent research reports. Weiss Ratings reissued a “sell (e+)” rating on shares of DocGo in a research report on Thursday, June 18th. Needham & Company LLC reiterated a “buy” rating and issued a $3.00 price objective on shares of DocGo in a research note on Tuesday, August 18th. Canaccord Genuity Group reiterated a “hold” rating and issued a $1.00 price objective on shares of DocGo in a research note on Tuesday, August 18th. Wall Street Zen raised shares of DocGo from a “sell” rating to a “hold” rating in a report on Saturday, May 16th. Finally, Cantor Fitzgerald restated an “overweight” rating on shares of DocGo in a research report on Monday, May 11th.
View Our Latest Research Report on DocGo
Hedge Funds Weigh In On DocGo
DocGo Price Performance
Shares of DCGO opened at $0.40 on Tuesday. The company’s fifty day moving average price is $0.56 and its 200-day moving average price is $0.60. DocGo has a 1-year low of $0.35 and a 1-year high of $1.65. The firm has a market capitalization of $39.84 million, a PE ratio of -0.21 and a beta of 0.94.
DocGo (NASDAQ:DCGO – Get Free Report) last issued its earnings results on Monday, August 17th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.06). The firm had revenue of $73.42 million during the quarter, compared to analysts’ expectations of $75.35 million. DocGo had a negative return on equity of 40.42% and a negative net margin of 65.29%. As a group, research analysts anticipate that DocGo will post -0.22 EPS for the current fiscal year.
DocGo Company Profile
DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.
In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.
Featured Stories
- Five stocks we like better than DocGo
- 3 Under-the-Radar Defense Stocks With Record Backlogs
- This Korea ETF Has Soared, But the Rally May Not Be Over
- Why Guidewire’s Post-Earnings Plunge May Not Last
- Ride-Share Reckoning: Tesla Drives Into Uber’s Lane
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.
